FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples
The Pharma Data
APRIL 15, 2022
director of the FDA’s Center for Devices and Radiological Health. The FDA continues to support the development of novel COVID-19 tests with the goal of advancing technologies that can help address the current pandemic and better position the U.S. for the next public health emergency.”. Source link: [link].
Let's personalize your content